<DOC>
	<DOCNO>NCT00040430</DOCNO>
	<brief_summary>The purpose study investigate safety image ability 111In-DAC used planar SPECT image detection breast cancer .</brief_summary>
	<brief_title>Study 111In-DAC Medical Imaging Agent Detection Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Inclusion Criteria Patients eligible study : Are nonpregnant , nonlactating female 18 year age old ( must agree use appropriate effective method birth control study 2 week study ) Are evaluate know suspect breast tumor ( must present either mammographic abnormality 10mm large mammographically occult palpable abnormality breast ) Have previously schedule biopsy surgical excision know suspected tumor breast Have sign inform consent form Exclusion Criteria Patients eligible study : Have history suspicion significant allergic reaction anaphylaxis 111InDAC component Have clinically unstable medical condition opportunistic infection , lifethreatening disease state , impair renal hepatic function immunosuppressed Are take take part investigational study within 30 day start study Have receive indium agent within 30 day start study Are able remain immobile scanning time Have take drug may damage kidney within 2 week start study Have abnormal laboratory test result : hemoglobin &lt; 9.5 gms/dl , serum creatinine &gt; 1.5 mg/100ml , alkaline phosphatase 2X upper limit normal Have undergone excisional and/or needle localization biopsy within 4 day prior start study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2003</verification_date>
</DOC>